| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 7.442 | 21.649 | 9.715 | 22 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 7.442 | 21.649 | 9.716 | 22 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 1.560 | 20.118 | 11.010 | 3.470 | 908 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 5.882 | 1.531 | -1.294 | -3.448 | -908 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 5.808 | 1.340 | -1.380 | -3.448 | -908 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Mars Intermed Cons Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 75 | 74 | 73 | 71 | 70 | 48 | 23 | 159 | 94 | 67 |
| Current Assets | 6.396 | 6.331 | 6.224 | 6.110 | 5.991 | 12.756 | 13.231 | 10.364 | 6.455 | 5.746 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 351 | 347 | 341 | 335 | 329 | 322 | 315 | 2.381 | 837 | 844 |
| Cash | 6.045 | 5.984 | 5.883 | 5.775 | 5.663 | 12.434 | 12.916 | 7.983 | 5.618 | 4.902 |
| Shareholders Funds | 4.343 | 4.299 | 4.226 | 4.149 | 4.068 | 9.799 | 10.922 | 9.576 | 6.099 | 5.158 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.128 | 2.106 | 2.070 | 2.032 | 1.993 | 3.006 | 2.332 | 961 | 476 | 655 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Mars Intermed Cons Srl